Document is current
Any future updates will be listed below
-
Authors
Mercuri, Eugenio
Finkel, Richard S. https://orcid.org/0000-0002-9351-7054
Muntoni, Francesco https://orcid.org/0000-0002-9102-5232
- License Information
-
More Information
Article History
Accepted: 26 May 2026
First Online: 17 June 2026
Competing interests
: E.M. reports funding to his institution to support clinical research from Biogen, Roche and Novartis; and having received personal advisory fees from Biogen, Roche, Novartis and Scholar Rock. R.S.F. reports funding to his institution to support clinical research from Biogen, Genentech/Roche, Novartis and Scholar Rock; spinal muscular atrophy (SMA) study (APNCR) group support from Cure SMA; and having received personal advisory fees from Biogen, Genentech/Roche, Novartis and Scholar Rock, and licensing fees from the Children’s Hospital of Philadelphia. F.M. reports funding to his institution to support clinical research from Biogen, Roche and Novartis; and having received personal advisory fees from Biogen, Roche, Novartis and Scholar Rock.
